Ramakrishnan, Swathi
https://orcid.org/0000-0001-8352-4704
Mayo Clinic
National Comprehensive Cancer Network
Citations 4
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Ganti, Apar Kishor P., Loo, B., Bassetti, Michael, Chiang, Anne, D’Avella, Christopher , Daly, Megan, Dowlati, Afshin, Edelman, Martin, Florsheim, Charles, Grecula, J.C., Hann, Christine, Khalil, Maya, Lee, R., Merritt, Robert E. , Mohindra, Nisha , Molina, Julian R. , Moran, C Solis, Mulvey, Claire K. , Osmundson, Evan C., Patel, S. B., Patil, Tejas, Puri, S., Qin, Angel, Tailor, Tina D. , Waqar, Saiama N., Cassara, Carly J., Ramakrishnan, Swathi , Ganti, Apar Kishor , Loo, Billy W. , Badiyan, Shahed N. , Bassetti, Michael, Bestvina, Christine M. , Chiang, Anne, Choudhury, Noura J. , Daly, Megan, Gold, Kathryn Ann , Goldman, Jonathan W. , Hann, Christine L. , Lee, Robert P. , Malhotra, Jyoti Dhar , Pokharel, Saraswati , Qin, Angel , Sands, Jacob , Shields, Misty Dawn , Waqar, Saiama N
Journal of the National Comprehensive Cancer Network | January 8, 2026 | Volume: 24 | Issue: 1 | Pages: No page available
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer provide recommendations for diagnostic workup, staging, and treatment. These NCCN Guidelines Insights highlight recent updates, with a particular focus on changes to systemic therapies and radiation treatment in the NCCN Guidelines for Small Cell Lung Cancer.
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Gajjar, Amar , Mahajan, Anita , Canan, Liz, Chi, Susan , Cluster, Andrew , Cole, Bonnie , Darlington, Wendy , Dorris, Kathleen , Elster, Jennifer , Franson, Andrea , Helgager, Jeffrey, Lin, Chi , Metrock, Laura, Nanda, Ronica H. , Partap, Sonia , Plant, Ashley , Reynolds, Renée M. , Stearns, Duncan , Storm, Phillip, Wang, Leo D. , Whipple, Nicholas , Zaky, Wafik , McMillian, Nicole R., Ramakrishnan, Swathi , Franson, Andrea , Bale, Tejus , Bowers, Daniel C. , Cohen, Kenneth J. , Coven, Scott L. , Ermoian, Ralph P. , George, Elizabeth , Landi, Daniel B. , Palmer, Joshua D. , Pruthi, Sumit , Wang, Anthony
Journal of the National Comprehensive Cancer Network | March 12, 2025 | Volume: 23 | Issue: 3 | Pages: 113-130
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Central Nervous System Cancers provide multidisciplinary diagnostic workup, staging, and treatment recommendations for diffuse high-grade gliomas and medulloblastomas in children and adolescents. This article summarizes the studies and panel discussion that serve as the rationale for comprehensive care recommendations included in the NCCN Guidelines for Pediatric Central Nervous System Cancers.
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025
Wood, Douglas E. , Kazerooni, Ella A. , Argento, Christine, Baines, Jonathan, Boer, Brian, Donington, Jessica , Eapen, Georgie A. , Ferguson, J. Scott , Hou, Lifang , Klippenstein, Donald, Kolansky, Ana S., Leung, Ann N. , Mazzone, Peter J. , Merritt, Robert E. , Norris, Kim, Onaitis, Mark W. , Pipavath, Sudhakar, Puri, Varun , Raz, Dan J. , Reddy, Chakravarthy, Reid, Mary E. , Sandler, Kim L. , Sears, Catherine R. , Tanoue, Lynn, Thacker, Amber L., Tong, Betty C. , Wei, Benjamin , McCullough, Beth, Ramakrishnan, Swathi , Hou, Lifang , Leung, Ann , Aberle, Denise R. , Brown, Lisa Marie , Kumar, Rohit , Leard, Lorriana E. , Sands, Jacob , Schabath, Matthew B. , Studts, Jamie L. , Thacker, Amber L., Travis, William D. , Westover, Kenneth D.
Journal of the National Comprehensive Cancer Network | January 15, 2025 | Volume: 23 | Issue: 1 | Pages: No page available
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening provide criteria for selecting individuals for screening and offer recommendations for evaluating and managing lung nodules detected during initial and subsequent annual screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Cohen, Joshua G. , Miller, David S. , Robertson, Sharon E. , Hendrickson, Andrea Wahner, Gray, Heidi J. , Hakam, Ardeshir, Jain, Angela, Konecny, Gottfried E. , Moroney, John W. , Ratner, Elena , Schorge, John O., Werner, Theresa L. , Chen, Lee-may, DeRosa, Marie, Eisenhauer, Eric , Leiserowitz, Gary S. , Litkouhi, Babak , McHale, Michael , Percac‐Lima, Sanja , Rodabaugh, Kerry J. , Vargas, Roberto , Jones, Frankie, Kovách, E, Hang, Lisa E., Ramakrishnan, Swathi , Armstrong, Deborah K. , Miller, David S , Liu, Joyce F. , Berchuck, Andrew , Backes, Floor , Grisham, Rachel Nicole , Leath, Charles A , Martin, Lainie P. , Matei, Daniela , Barroilhet, Lisa , Uppal, Shitanshu , Gershenson, David M. , Thaker, Premal H. , Zsíros, Emese , Behbakht, Kian , Kovach, Emily, Alvarez, Ronald D.
Journal of the National Comprehensive Cancer Network | October 16, 2024 | Volume: 22 | Issue: 8 | Pages: 512-519
The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.